ARQT
Arcutis Biotherapeutics, Inc.
2.03
USD
This page is just a preview of the data found in TrendSpider’s full version
Arcutis Biotherapeutics, Inc. stock is up 6.28% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 December’s closed higher than November. In the last 1 Unusual Options Trades, there were 1 CALL. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 12 Oct 16:52 | 15 Mar, 2024 | 2.50 | 6 |
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of arq-154.
